Ranolazine
Ranolazine is a late sodium current inhibitor used in chronic angina treatment and cardiovascular research. It modulates intracellular sodium levels, thereby affecting calcium handling during ischemia, as demonstrated in rabbit myocardial ischemia models. Its applications extend to in vitro electrophysiology studies and in vivo investigations of cardiac metabolism and arrhythmias.
Product Specifications
CAS Number
95635-55-5
Product Name Alternative
Ranexa, Ranolazine, Sodium Channel, RS 43285-003, SodiumChannel, Na channels, Na+ channels, inhibit, Inhibitor, Ca channels, Calcium Channel, Ca2+ channels, CalciumChannel, CVT 303, CVT303, CVT-303
Field of Research
Metabolism Research, Pharmacology & Drug Discovery
Purity
98.13% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.68 mM) ; DMSO:100 mg/mL (233.9 mM) ; Ethanol:16 mg/mL (37.42 mM)
Smiles
COC1=CC=CC=C1OCC (O) CN1CCN (CC (=O) NC2=C (C) C=CC=C2C) CC1
Molecular Formula
C24H33N3O4
Molecular Weight
427.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15312510 1 Vial
Lentiviral human POLR3E shRNA (UAS) - Lentiviral human POLR3E shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 